---
$id: https://graph.org.ai/products/commodity/51441612
$type: Product
source: UNSPSC
code: "51441612"
title: "Ibritumomab tiuxetan 90y"
class: "51441600"
classTitle: "Diagnostic agents and radiopharmaceuticals"
family: "51440000"
familyTitle: "Radiopharmaceuticals and contrast media"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ibritumomab tiuxetan 90y

**UNSPSC Code**: 51441612
**Class**: [Diagnostic agents and radiopharmaceuticals](Diagnostic agents and radiopharmaceuticals.mdx)
**Family**: [Radiopharmaceuticals and contrast media](../Radiopharmaceuticals and contrast media.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an immunoconjugate, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 4Q52C550XK. The European Medicines Agency schedules Ibritumomab tiuxetan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20031. Ibritumomab tiuxetan generally arises in the molecular formula C23H32N5O10S. The term IBRITUMOMAB TIUXETAN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, volume 14, no. 1, 2000, list 43.) SMILES: none.

